These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 22664472)

  • 1. Challenges in design of translational nanocarriers.
    Sun Q; Radosz M; Shen Y
    J Control Release; 2012 Dec; 164(2):156-69. PubMed ID: 22664472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDL-mimicking peptide-lipid nanoparticles with improved tumor targeting.
    Zhang Z; Chen J; Ding L; Jin H; Lovell JF; Corbin IR; Cao W; Lo PC; Yang M; Tsao MS; Luo Q; Zheng G
    Small; 2010 Feb; 6(3):430-7. PubMed ID: 19957284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular drug delivery: nanomedicine applications.
    Vandervoort J; Ludwig A
    Nanomedicine (Lond); 2007 Feb; 2(1):11-21. PubMed ID: 17716187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organic nanocarriers for cancer drug delivery.
    López-Dávila V; Seifalian AM; Loizidou M
    Curr Opin Pharmacol; 2012 Aug; 12(4):414-9. PubMed ID: 22465543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesoporous silica nanoparticles as nanocarriers.
    Wu SH; Hung Y; Mou CY
    Chem Commun (Camb); 2011 Sep; 47(36):9972-85. PubMed ID: 21716992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Advancement and Obstacles in Improving the Stability of Nanocarriers for Precision Drug Delivery in the Field of Nanomedicine.
    Mahajan K; Bhattacharya S
    Curr Top Med Chem; 2024; 24(8):686-721. PubMed ID: 38409730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications.
    Fleige E; Quadir MA; Haag R
    Adv Drug Deliv Rev; 2012 Jun; 64(9):866-84. PubMed ID: 22349241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface receptor targeted biomimetic apatite nanocrystals for cancer therapy.
    Iafisco M; Delgado-Lopez JM; Varoni EM; Tampieri A; Rimondini L; Gomez-Morales J; Prat M
    Small; 2013 Nov; 9(22):3834-44. PubMed ID: 23606568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: a multifunctional nanocarrier system for cancer diagnosis and treatment.
    Cho HS; Dong Z; Pauletti GM; Zhang J; Xu H; Gu H; Wang L; Ewing RC; Huth C; Wang F; Shi D
    ACS Nano; 2010 Sep; 4(9):5398-404. PubMed ID: 20707381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery.
    Torchilin VP
    Biopolymers; 2008; 90(5):604-10. PubMed ID: 18381624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation.
    Yadav SC; Kumari A; Yadav R
    Peptides; 2011 Jan; 32(1):173-87. PubMed ID: 20934475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid based nanocarriers: a translational perspective.
    Mishra DK; Shandilya R; Mishra PK
    Nanomedicine; 2018 Oct; 14(7):2023-2050. PubMed ID: 29944981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer drug delivery with nanoparticles.
    Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U
    In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporation of liquid lipid in lipid nanoparticles for ocular drug delivery enhancement.
    Shen J; Sun M; Ping Q; Ying Z; Liu W
    Nanotechnology; 2010 Jan; 21(2):025101. PubMed ID: 19955616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysaccharide-based nucleic acid nanoformulations.
    Raemdonck K; Martens TF; Braeckmans K; Demeester J; De Smedt SC
    Adv Drug Deliv Rev; 2013 Aug; 65(9):1123-47. PubMed ID: 23680381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theranostic nanoparticles engineered for clinic and pharmaceutics.
    Ma X; Zhao Y; Liang XJ
    Acc Chem Res; 2011 Oct; 44(10):1114-22. PubMed ID: 21732606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers.
    Torchilin VP
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):548-58. PubMed ID: 18053612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted pharmaceutical nanocarriers for cancer therapy and imaging.
    Torchilin VP
    AAPS J; 2007 May; 9(2):E128-47. PubMed ID: 17614355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium phosphate nanocarriers for drug delivery to tumors: imaging, therapy and theranostics.
    Huang D; He B; Mi P
    Biomater Sci; 2019 Oct; 7(10):3942-3960. PubMed ID: 31414096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
    Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
    Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.